
Topic
Label Warnings
Boxed warnings, precautions, contraindications, monitoring requirements, and commercial implications of safety language.

Policy· July 25, 2026 · 28 min read
By Ran Chen#Label Warnings#Boxed Warning#FDA Approval

Evidence· July 14, 2026 · 17 min read
H1 Antihistamines in FAERS: 925,032 Adverse-Event Reports

Evidence· July 13, 2026 · 16 min read
ADHD Medications in FAERS: 194,052 Adverse-Event Reports by the Numbers

Evidence· July 12, 2026 · 17 min read
Non-HIV Antivirals in FAERS: 508,024 Adverse-Event Reports by the Numbers

Evidence· July 10, 2026 · 17 min read
Anticoagulant Adverse Events in FAERS: 244,000 Reports and Bleeding/HIT Profiles

Evidence· July 10, 2026 · 17 min read
Calcineurin Inhibitor Adverse Events in FAERS: 275,000 Reports and Key Safety Signals

Evidence· July 9, 2026 · 16 min read
Benzodiazepines in FAERS: Adverse Events, Dependence, and Safety Signals

Evidence· July 8, 2026 · 23 min read
Diuretic Adverse Events in FAERS: 763,000 Reports Across Three Sub-Classes

Evidence· July 8, 2026 · 28 min read
NSAID Adverse Events in FAERS: 1.5 Million Reports and the Non-Aspirin Signal Profile

Evidence· July 7, 2026 · 21 min read